MindWalk Q1 revenue up 21%, loss widens

HYFT grew revenue and margins but posted a larger loss, while securing a US$30 million unsecured credit facility to fund its shift to recurring platform revenue.

Rhea-AI Filing Summary

MindWalk Holdings Corp. (HYFT) reported fiscal first quarter 2027 revenue of $3.8 million, up 21% year over year, with gross profit rising 47% to $2.2 million and gross margin expanding to 58.6% from 48.3%. The quarter marked the commercial launch of its ReefIQ™ data platform and a shift toward recurring, platform-based revenue.

Operating expenses increased to $8.4 million from $5.7 million, driven mainly by higher sales and marketing and non-cash share-based compensation, leading to a larger operating loss of $6.1 million. Net loss from continuing operations was $6.1 million, or $0.13 per share, compared with $4.1 million, or $0.09 per share. Net cash used in operating activities was $4.0 million, modestly improved from $4.2 million, and cash stood at $7.6 million as of July 31, 2026.

Subsequent to quarter-end, MindWalk received a binding commitment for a US$30 million senior unsecured revolving credit facility at a fixed 7.00% rate, with no financial maintenance covenants, no warrants or conversion feature, and no asset pledge, intended to support ReefIQ™ and LensAI™ enterprise onboarding and the transition to recurring, platform-based revenue without equity dilution.

Positive

• Revenue grew 21% year over year to $3.8 million, with gross margin expanding to 58.6% from 48.3%, indicating higher-margin business mix and improved profitability at the gross level.
• MindWalk obtained a binding commitment for a US$30 million unsecured revolving credit facility at 7.00% with no covenants, warrants, conversion feature, or asset pledge, adding non-dilutive balance sheet flexibility.
• Net cash used in operating activities improved slightly to $4.0 million from $4.2 million despite higher operating expenses, helped by the largely non-cash nature of the G&A increase.

Negative

• Net loss from continuing operations widened to $6.1 million (or $0.13 per share) from $4.1 million ($0.09 per share), reflecting significantly higher operating expenses.
• Total operating expenses increased 47% to $8.4 million, including a jump in sales and marketing to $3.2 million and higher general and administrative costs.
• Cash declined to $7.6 million at July 31, 2026 from $11.3 million at April 30, 2026, driven by continued operating and investing cash outflows.

Filing Explained

Although the release describes a US$30 million credit facility, the disclosure places it at the binding-commitment stage: MindWalk and Sanabil still must negotiate a definitive agreement, with closing targeted within 60 days, so the disclosed amount is financing capacity rather than a completed or drawn loan.

Key Figures

Revenue: $3.8 million Gross margin: 58.6% Operating loss: $6.1 million +5 more

8 metrics

Revenue $3.8 million Three months ended July 31, 2026; up 21.3% from $3.2 million in prior-year period

Gross margin 58.6% Three months ended July 31, 2026; up from 48.3% in prior-year period

Operating loss $6.1 million Three months ended July 31, 2026; compared with $4.2 million in prior-year period

Net loss from continuing operations $6.1 million Three months ended July 31, 2026; $0.13 loss per share vs $0.09 prior year

Adjusted EBITDA from continuing operations −$5.1 million Three months ended July 31, 2026; compared with −$3.7 million in prior-year period

Net cash used in operating activities $4.0 million Three months ended July 31, 2026; slightly improved from $4.2 million prior year

Cash balance $7.6 million As of July 31, 2026; down from $11.3 million at April 30, 2026

Revolving credit facility commitment US$30 million at 7.00% Senior unsecured facility, drawn as needed, with no financial maintenance covenants, warrants, conversion feature, or asset pledge

Key Terms

Adjusted EBITDA, non-IFRS financial measure, senior unsecured revolving credit facility, discontinued operations, +2 more

6 terms

Adjusted EBITDA financial

"This release includes Adjusted EBITDA, a non-IFRS financial measure defined as net loss before income taxes, amortization and depreciation, interest, foreign exchange gains and losses, and share-based payments."

Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.

non-IFRS financial measure financial

"This release includes Adjusted EBITDA, a non-IFRS financial measure defined as net loss before income taxes, amortization and depreciation, interest, foreign exchange gains and losses, and share-based payments."

A non-IFRS financial measure is a performance number a company reports that is not defined by official accounting rules and usually adjusts standard results to show what management believes is the company’s underlying performance. Think of it like a photo with a custom filter: it can make important features clearer but may also hide blemishes, so investors use it to understand management’s view while checking how the adjustments were made and reconciled to the official numbers.

senior unsecured revolving credit facility financial

"a binding commitment from Sanabil (Cayman) for a senior unsecured revolving credit facility of up to US$30 million at a fixed 7.00% interest rate, drawn as needed."

A senior unsecured revolving credit facility is a bank loan line that a company can draw, repay and redraw up to an agreed limit, similar to a company credit card. It is “senior” because lenders are paid before other creditors if the company fails, and “unsecured” because it isn’t backed by specific assets; investors watch it for signals about a company’s short-term cash flexibility, borrowing cost and financial risk.

discontinued operations financial

"The prior-year period includes $1.1 million of net income from discontinued operations."

Discontinued operations are parts of a company that it has decided to sell or shut down, and no longer plans to run in the future. This matters to investors because it helps them understand which parts of the business are ongoing and which are being phased out, providing a clearer picture of the company’s current performance and future prospects. Think of it like a store closing a department—it no longer contributes to sales or profits.

Bio-Native AI technical

"MindWalk Holdings Corp. (NASDAQ: HYFT) is a Bio-Native AI company building the BioIntelligence infrastructure that life sciences AI and agentic AI require."

share-based payments financial

"This release includes Adjusted EBITDA, a non-IFRS financial measure defined as net loss before income taxes, amortization and depreciation, interest, foreign exchange gains and losses, and share-based payments."

Share-based payments are compensation a company gives using its own stock or stock options instead of cash, similar to paying employees with slices of the business rather than dollars. They matter to investors because they can dilute existing ownership when new shares are issued and are recorded as a non-cash expense that reduces reported profits, so they affect earnings, per-share metrics and incentives that drive long-term company performance.

Earnings Snapshot

Revenue: $3.8 million

Fiscal first quarter 2027 ended July 31, 2026

Revenue $3.8 million Up 21.3% from $3.2 million in the prior-year quarter

Gross margin 58.6% Up from 48.3% in the prior-year quarter, a 10.3 percentage point increase

Net loss from continuing operations $6.1 million (−$0.13 per share) Wider than $4.1 million (−$0.09 per share) in the prior-year quarter

Adjusted EBITDA from continuing operations −$5.1 million More negative than −$3.7 million in the prior-year quarter

Net cash used in operating activities $4.0 million Slightly improved from $4.2 million in the prior-year quarter

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How did MindWalk (HYFT) perform financially in its fiscal Q1 2027?

MindWalk reported revenue of $3.8 million, up 21% year over year, with gross margin of 58.6%. Operating loss was $6.1 million, and net loss from continuing operations was $6.1 million, or $0.13 per share, compared with $4.1 million, or $0.09 per share.

What are the key growth and margin trends for HYFT this quarter?

Revenue rose 21.3% to $3.8 million, while gross profit increased 47.1% to $2.2 million. Gross margin expanded to 58.6% from 48.3%, helped by revenue growth on essentially flat cost of sales at $1.6 million.

How large is MindWalk’s new credit facility and what are its terms?

MindWalk received a binding commitment for a US$30 million senior unsecured revolving credit facility at a fixed 7.00% interest rate, drawn as needed. It has no financial maintenance covenants, no warrants or conversion feature, and no pledge of assets.

What drove HYFT’s higher operating expenses and loss in fiscal Q1 2027?

Operating expenses rose to $8.4 million from $5.7 million, mainly due to higher sales and marketing spending of $3.2 million to support the ReefIQ™ launch and increased general and administrative expenses of $3.9 million, largely from non-cash share-based compensation, widening the operating loss.

What was MindWalk’s cash position and cash burn in fiscal Q1 2027?

Cash was $7.6 million at July 31, 2026, down from $11.3 million at April 30, 2026. Net cash used in operating activities was $4.0 million, slightly better than the $4.2 million used in the prior-year quarter.

How did HYFT’s Adjusted EBITDA change in fiscal Q1 2027?

Adjusted EBITDA from continuing operations was negative $5.1 million, compared with negative $3.7 million a year earlier, reflecting increased operating investment. The figure is calculated by adjusting net loss for taxes, amortization and depreciation, interest, foreign exchange, and share-based payments.

What strategic milestones did MindWalk (HYFT) achieve with ReefIQ™?

MindWalk commercially launched ReefIQ™, validated a production deployment on AMD Instinct GPUs with AMD and Vultr, and reported that about 80% of its commercial funnel by value is now in partnership-structured engagements, including platform-based enterprise opportunities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 04:59 PM Accepted by SEC EDGAR 09/14/2026 - 04:58 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of September, 2026.

Commission File Number: 001-39530

ImmunoPrecise Antibodies Ltd.

Industrious 823 Congress Ave Suite 300 Austin, Texas 78701, United States

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit	Description
99.1	Earnings Release dated September 14, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IMMUNOPRECISE ANTIBODIES LTD.
Date: September 14, 2026
	By:	/s/ Jennifer Bath
	Name:	Jennifer Bath
	Title:	Chief Executive Officer

99.1

MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027

ReefIQ™ launched commercially, and a US$30 million unsecured credit facility commitment, drawn only as needed, adds balance-sheet flexibility with no dilution.

AUSTIN, Texas (September 14, 2026) - MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today reported financial results for its fiscal 2027 first quarter ended July 31, 2026. The quarter marked the commercial launch of ReefIQ™, MindWalk's data platform, and the start of its shift toward recurring, platform-based revenue.

•Revenue increased 21.3% year over year to $3.8 million.

•Gross profit increased 47.1% to $2.2 million; gross margin expanded to 58.6% from 48.3%.

•Net cash used in operating activities declined to $4.0 million from $4.2 million, even as MindWalk stepped up sales and marketing investment behind the ReefIQ™ launch and enterprise rollout.

•Net loss from continuing operations was $6.1 million, or $0.13 per share, compared with $4.1 million, or $0.09 per share, reflecting planned investment in the commercial infrastructure for ReefIQ™ enterprise adoption.

Business Highlights

•Commercially launched ReefIQ™, MindWalk's data platform, in June, and is in active negotiations with multiple large pharmaceutical companies on enterprise deployments.

•Roughly 80% of the commercial funnel by value now sits in partnership-structured engagements rather than discrete projects, spanning data management, ReefIQ, and multi-target discovery.

•Validated a production deployment on AMD Instinct GPUs with engineering partner AMD and Vultr, giving ReefIQ™ the compute capacity to onboard enterprise clients and run more programs at lower cost as recurring revenue scales.

•Subsequent to quarter-end, obtained a binding commitment for a senior unsecured revolving credit facility of up to US$30 million at a fixed 7.00% rate, with no financial maintenance covenants, no warrants or conversion feature, and no pledge of assets, providing the balance sheet to scale ReefIQ™ enterprise onboarding without dilution.

"We delivered a strong quarter, with revenue up 21% and gross margin expanding to 59%, while launching ReefIQ™ into a market moving toward exactly what we built," said Jennifer Bath, PhD, President and Chief Executive Officer of MindWalk. "Our discovery business, which pairs wet-lab biologics with in silico capabilities for 19 of the top 20 pharmaceutical companies, is the foundation. On top of it, ReefIQ opens the door to enterprise partnerships of a scale well beyond our historical recurring agreements, and new partner engagements under discussion are increasingly structured as platform partnerships, where we share in the economics of the assets we help create. The larger loss this quarter reflects deliberate investment in ReefIQ's enterprise rollout."

"The US$30 million facility we announced today gives us the flexibility to fund that rollout as needed, without issuing a single share," continued Dr. Bath. "No warrants or conversion feature, and no pledge of our assets. Our commercial model is shifting to recurring, compounding revenue with ReefIQ at its center, and this gives us the balance sheet to make that shift on our own terms."

Fiscal First Quarter 2027 Financial Summary

Quarter ended July 31 (in thousands of Canadian dollars, except per-share data)

Metric	FQ1 2027	FQ1 2026	Change
Revenue	3,834	3,161	+21%
Gross profit	2,246	1,527	+47%
Gross margin	58.6%	48.3%	+10.3 pts
Total operating expenses	8,375	5,686	+47%
Operating loss	(6,129)	(4,159)	+47%
Net loss from continuing operations	(6,085)	(4,088)	+49%
Net loss for the quarter (1)	(6,085)	(2,959)	+106%
Loss per share, continuing operations	(0.13)	(0.09)	(0.04)
Net cash used in operating activities	(4.0M)	(4.2M)	-4%
Adjusted EBITDA from continuing operations	(5,091)	(3,702)	-38%

(1) The prior-year period includes $1.1 million of net income from discontinued operations. There were no discontinued operations in the current period.

Non-IFRS Measures. This release includes Adjusted EBITDA, a non-IFRS financial measure defined as net loss before income taxes, amortization and depreciation, interest, foreign exchange gains and losses, and share-based payments. Management uses Adjusted EBITDA to evaluate operating performance. It has no standardized meaning under IFRS and may not be comparable to similar measures presented by other companies. A reconciliation of net loss to Adjusted EBITDA is provided at the end of this release.

Fiscal First Quarter Financial Results

Revenue for the three months ended July 31, 2026, was $3.8 million, up 21.3% from $3.2 million in the prior-year period. Gross profit rose 47.1% to $2.2 million, and gross margin expanded to 58.6% from 48.3%, as revenue grew on a cost of sales that held at $1.6 million.

Operating expenses were $8.4 million, compared with $5.7 million. Sales and marketing expenses rose to $3.2 million from $1.3 million, reflecting planned investment in the commercial team and infrastructure to bring ReefIQ™ to market and to onboard and scale enterprise deployments as agreements are signed, including non-recurring costs incurred in the quarter. General and administrative expenses were $3.9 million, compared with $3.3 million, with the increase primarily non-cash stock-based compensation. Research and development expenses were $1.3 million, compared with $1.0 million, reflecting additional engineering capacity to support the commercial development of the platform.

Operating loss was $6.1 million, compared with $4.2 million, as planned investment in the ReefIQ enterprise rollout and higher non-cash stock-based compensation more than offset a $0.7 million increase in gross profit. Net loss from continuing operations was $6.1 million, or $0.13 per share, compared with $4.1 million, or $0.09 per share. Total net loss was $6.1 million, compared with $3.0 million in the prior-year period, which included $1.1 million of income from discontinued operations.

Net cash used in operating activities was $4.0 million, compared with $4.2 million in the prior-year period, despite the increase in operating expenses, reflecting the non-cash nature of much of the G&A increase. Cash was $7.6 million at July 31, 2026, compared with $11.3 million at April 30, 2026, before the US$30 million facility commitment described below.

Subsequent Event

On September 14, 2026, MindWalk announced a binding commitment from Sanabil (Cayman) for a senior unsecured revolving credit facility of up to US$30 million at a fixed 7.00% interest rate, drawn as needed. The facility carries no financial maintenance covenants, no warrants or conversion feature, and no pledge of MindWalk assets. Proceeds are intended to support MindWalk's shift to recurring, platform-based revenue: onboarding ReefIQ™ and LensAI™ enterprise clients as agreements are signed, and participating in the platform partnerships that increasingly define its commercial model, along with its biologics programs, working capital, and general corporate purposes. The term sheet is binding on both parties, and MindWalk and Sanabil (Cayman) will negotiate a definitive credit agreement with a target closing within 60 days.

Conference Call and Webcast Details

Event Date and Time: Monday, September 14, 2026, at 5:00 p.m. Eastern Time

The conference call will be webcast live and available for replay via a link provided in the Events section of the Company’s Investor Relations pages at: https://ir.mindwalkai.com/events-and-presentations/default.aspx

Analyst registration URL: https://events.q4inc.com/analyst/231176031?pwd=m63SIFiS

Webcast Attendee URL: https://events.q4inc.com/attendee/231176031

Anyone listening to the call is encouraged to read the Company’s periodic reports available on the Company’s profile at www.sedarplus.ca and www.sec.gov, including the discussion of risk factors and historical results of operations and financial condition in those reports.

About MindWalk Holdings Corp.

MindWalk Holdings Corp. (NASDAQ: HYFT) is a Bio-Native AI company building the BioIntelligence infrastructure that life sciences AI and agentic AI require, integrating AI, data, and advanced wet lab capabilities into one connected discovery ecosystem. At its core is HYFT® Technology, a proprietary, function-aware representation of biology. Its HYFT pattern-objects span sequence and structural biology and, refined over 20 years of curation, form a continuously evolving biological representation of 660 million patterns and 25 billion relationships. This enriched biological representation is the architecture behind ReefIQ™, the biological data substrate that provides context for life sciences, enriching data at ingestion and growing more valuable with each program run on it, and LensAI™, the reasoning and application layer for target discovery, candidate diligence, portfolio decision support, and the agentic AI workflows pharmaceutical companies are now deploying. By design, value compounds in this HYFT representation layer, not in any individual AI model that runs on top of it.

Investor Contact

Louie Toma, CPA, CFA, Managing Director, CoreIR, investors@mindwalkai.com

Trademarks

HYFT® is a registered trademark of MindWalk Holdings Corp. ReefIQ™ and LensAI™ are trademarks of MindWalk Holdings Corp. or its subsidiaries; ReefIQ™ registration is pending. All other trademarks are the property of their respective owners.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable United States and Canadian securities laws. Forward-looking statements are based on management’s current expectations and assumptions and are subject to known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially, including: risks relating to MindWalk’s history of net losses and its ability to achieve or sustain profitability; the level and trend of operating cash usage and MindWalk’s ability to fund operations; the risk that MindWalk and the lender do not negotiate and execute a definitive credit agreement, or do not do so by the target closing date, and MindWalk’s ability to satisfy the conditions to closing and to drawing under the facility; the market acceptance and commercial outcomes of ReefIQ™ and LensAI™, including the ability to convert engagements into contracted, recurring arrangements; the build-out and certification of compliance capabilities for regulated workloads; the technical performance of AI-based discovery methods and of the underlying compute infrastructure; the outcomes and financial effects of the divestiture of non-core operations; intellectual property risks, including the status and scope of pending patent applications; the ability to enter into pharmaceutical, infrastructure, or other partnership arrangements; competition; regulatory determinations; and capital markets conditions. Additional information is available in MindWalk’s Annual Report on Form 20-F and other filings on SEDAR+ (sedarplus.ca) and EDGAR (sec.gov/edgar). Except as required by law, MindWalk undertakes no obligation to update any forward-looking statement. [Legal to review tailored risk factors before issuance.]

Source: MindWalk Holdings Corp.

The reconciliation of Net Loss of continuing operations to Adjusted EBITDA is presented in the table below:

		Three months ended July 31,
(in thousands)		2026 $				2025 $
Net loss			(6,085	)			(4,088	)
Income taxes			158				(91	)
Amortization and depreciation			266				201
Foreign exchange realized loss			(23	)			136
Interest expense			55				59
Interest, accretion and other income			(18	)			(5	)
Unrealized foreign exchange loss			(184	)			31
Share-based payments			740				55
Adjusted EBITDA			(5,091	)			(3,702	)

*All financial figures are in Canadian Dollars (CAD) unless otherwise stated.

MINDWALK HOLDINGS CORP.

CONDENSED INTERM CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS

(Unaudited - Expressed in Canadian dollars)

		Three months ended July 31,
(in thousands, except share data)		2026 $				2025 $
REVENUE			3,834				3,161
COST OF SALES			1,588				1,634
GROSS PROFIT			2,246				1,527
EXPENSES
Research and development			1,285				1,049
Sales and marketing			3,196				1,343
General and administrative			3,894				3,294
			8,375				5,686
Loss before other income (expenses) and income taxes			(6,129	)			(4,159	)
OTHER INCOME (EXPENSES)
Grant income			—				6
Interest, accretion and other income			18				5
Unrealized foreign exchange loss			184				(31	)
			202				(20	)
Loss before income taxes and discontinued operations			(5,927	)			(4,179	)
Income taxes			(158	)			91
NET LOSS FROM CONTINUING OPERATIONS			(6,085	)			(4,088	)
NET INCOME FROM DISCONTINUED OPERATIONS			—				1,129
NET LOSS FOR THE PERIOD			(6,085	)			(2,959	)
OTHER COMPREHENSIVE INCOME (LOSS)
Items that will be reclassified subsequently to loss
Exchange difference on translating foreign operations			(18	)			70
COMPREHENSIVE LOSS FOR THE PERIOD			(6,103	)			(2,889	)
LOSS PER SHARE FROM CONTINUING OPERATIONS– BASIC AND DILUTED			(0.13	)			(0.09	)
INCOME PER SHARE FROM DISCONTINUED OPERATIONS– BASIC AND DILUTED			—				0.02
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING			46,807,089				46,154,118

MINDWALK HOLDINGS CORP.

CONDENSED INTERM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(Unaudited - Expressed in Canadian dollars)

(in thousands)		July 31, 2026 $				April 30,  2026 $
ASSETS
Current assets
Cash			7,623				11,348
Amounts receivable, net			2,020				2,529
Taxes receivable			347				472
Inventory			611				492
Unbilled revenue			851				581
Prepaid expenses			762				798
			12,214				16,220
Restricted cash			128				126
Deposit on equipment			26				25
Property and equipment			3,997				4,047
Deferred tax asset			958				958
Total assets			17,323				21,376
LIABILITIES
Current liabilities
Accounts payable and accrued liabilities			5,442				4,178
Deferred revenue			529				1,073
Income taxes payable			188				81
Leases			483				457
			6,642				5,789
Leases			3,001				3,069
Deferred income tax liability			769				769
Total liabilities			10,412				9,627
SHAREHOLDERS' EQUITY
Share capital			137,788				137,263
Contributed surplus			14,848				14,108
Accumulated other comprehensive income			3,103				3,121
Accumulated deficit			(148,828	)			(142,743	)
			6,911				11,749
Total liabilities and shareholders’ equity			17,323				21,376

MINDWALK HOLDINGS CORP.

CONDENSED INTERM CONSOLIDATED STATEMENTS OF CASH FLOWS

For the three months ended July 31, 2026 and 2025

(Unaudited - Expressed in Canadian Dollars)

		Three months ended July 31,
(in thousands)		2026 $				2025 $
Operating activities:						(Note 2)
Net loss for the period			(6,085	)			(2,959	)
Items not affecting cash:
Amortization and depreciation			266				942
Foreign exchange			(142	)			41
Share-based expense			740				55
			(5,221	)			(1,921	)
Changes in non-cash working capital related to operations:
Amounts receivable			581				(850	)
Inventory			(119	)			(84	)
Unbilled revenue			(237	)			(627	)
Prepaid expenses			39				(329	)
Accounts payable and accrued liabilities			1,216				(986	)
Sales and income taxes payable and receivable			214				279
Deferred revenue			(515	)			305
Net cash used in operating activities			(4,042	)			(4,213	)
Investing activities:
Purchase of property and equipment			(78	)			(282	)
Deferred acquisition payments			—				(312	)
Net cash used in investing activities			(78	)			(594	)
Financing activities:
Proceeds on share issuance, net of transaction costs			525				(48	)
Repayment of leases			(179	)			(323	)
Net cash used in financing activities			346				(371	)
Increase (decrease) in cash during the period			(3,774	)			(5,178	)
Cash included in asset held for sale			—				(646	)
Foreign exchange			51				57
Cash – beginning of the period			11,474				10,791
Cash – end of the period			7,751				5,024
Cash is comprised of:
Cash			7,623				4,897
Restricted cash			128				127
			7,751				5,024
Cash paid for interest			—				—
Cash paid for income tax			—				—
Cash from discontinued operations:
Net cash used in operating activities			—				754
Net cash used in investing activities			—				(100	)
Net cash used in financing activities			—				(359	)

Source: MindWalk Holdings Corp.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EX-99.1 427.5 KB